---
title: CROs offering Analytical Method Development & Validation with Cell Therapy
path: /explore/analytical-development/cell-therapy
companies_count: 17
---

# CROs offering Analytical Method Development & Validation with Cell Therapy

17 published CROs match Analytical Method Development & Validation and Cell Therapy.

Locations in this set include United States, China, India, Netherlands, Singapore, and South Korea.

Capabilities that show up most often in this set: Bioanalysis, ICH Stability Studies, In Vivo PK / PD Studies, Ligand-Binding Bioanalysis (Large Molecule), and Preclinical In Vitro Studies.

## Matching companies

- [Allucent](/companies/allucent)
  - Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies.
- [Altasciences](/companies/altasciences)
  - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.
- [Aragen Life Sciences](/companies/aragen)
  - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- [Frontage Laboratories](/companies/frontagelab)
  - Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.
- [GenoSafe](/companies/genosafe)
  - GenoSafe is an analytical CRO for gene and cell therapies, innovative vaccines and DNA/RNA-based products. It offers preclinical analytical testing, quality control method development for ATMPs, and clinical sample bioanalysis.
- [Noble Life Sciences](/companies/noblelifesci)
  - Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.
- [NorthEast BioLab](/companies/nebiolab)
  - Bioanalytical CRO providing PK/PD, immunogenicity (ADA/nAb), cytokine, and biomarker assays across LC-MS, Meso Scale Discovery, ELISA, and ddPCR platforms. Operates GLP/GCLP-compliant facilities and reports DEA and CT approval for Schedule I–IV bioanalysis.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [ProBio](/companies/probio)
  - ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
- [Proone Labs](/companies/proonelabs)
  - Proone Labs provides preclinical pharmacology, drug discovery, and regulatory support services to biotech startups, traditional pharma, and in-silico companies. The team has delivered 30+ assays, 50+ cell lines, and supported 4 FDA drug approvals across multiple therapeutic areas.
- [SGVector](/companies/sgvector)
  - SGVector develops and manufactures viral vectors for cell and gene therapies, offering vector design, process development, scale-up, and analytical testing services with a scalable suspension-based platform.
- [Sannova](/companies/sannova)
  - Sannova provides bioanalytical and analytical CRO services, including immunogenicity and ligand binding assays, PK testing, DMPK services, extractables and leachables, nitrosamine testing, and pharmaceutical stability testing. Its listed work spans small molecules, biologics and biosimilars, and cell and gene therapies.
- [Solvias](/companies/solvias)
  - Global cGMP contract research organization providing comprehensive analytical services for drug development, from preclinical through commercialization, with expertise in biologics, cell & gene therapies, and small molecules.
- [Sword Bio](/companies/swordbio)
  - Bioanalytical CRO offering ligand binding assay development, PK, immunogenicity (ADA and NAb), and custom biomarker assays under non-GLP, spirit-of-GLP, and GLP conditions. Supports clients from discovery through clinical Phase IV.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [WuXi AppTec](/companies/wuxiapptec)
  - Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
- [uBriGene](/companies/ubrigene)
  - uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.